Home Blog Page 61

BioSteel Welcomes New President

0

 

The company appointed Bruce Jacobson as President of BioSteel, who, together with Co-Founders John Celenza and Michael Cammalleri, will be responsible for accelerating the growth of BioSteel into a top-4 sports hydration company.

Jacobson joins BioSteel with a wealth of experience from the beverage industry. Having served in several senior leadership roles, he is an experienced brand builder and business strategist who has led organizations to best-in-class growth and market dominance.

Most recently, Jacobson served on the advisory board and as Chief Operating Officer of an alcohol seltzer company, where he led a team in scaling the business to achieve profitable growth while balancing its entrepreneurial spirit and identity. Prior to that role, he spent 17 years at Constellation Brands, including four years in the role of Chief Commercial Officer, where he and his team achieved 36 consecutive quarters of industry-leading growth while delivering an aggregate of more than $5B in revenue and strong margins.

“Bruce will be an invaluable addition to the company’s leadership team as BioSteel continues to grow at a record pace by challenging the status quo in hydration,” said David Klein, CEO of Canopy Growth. “With deep experience building brands, driving profitability, developing distribution strategies, and leading cross-functional teams, we are confident that Bruce will complement and enhance the capabilities of the current leadership team and further advance BioSteel’s standing in the market.”

“It is an honour to join BioSteel and be a part of an innovative challenger brand that is already revolutionizing the sports hydration industry,” said Jacobson. “I’ve seen first-hand the passion that everyone at BioSteel brings to the table for our brand and products, and I am eager to partner with this exceptional team to build on the success to date and accelerate our growth into the future.”

Founded in 2009 by NHL veteran Michael Cammalleri and business partner John Celenza, BioSteel has achieved a reputation for being the hydration product of choice for athletes and consumers looking for a healthy alternative. The brand is committed to using premium ingredients, maintaining product transparency, and delivering essential nutrients needed to support physical activity. Each electrolyte-packed sports drink comes in an eco-friendly 16.7 fl oz Tetra Pak, in flavours ranging from Blue Raspberry, Mixed Berry, Peach Mango, Rainbow Twist and White Freeze to keep consumers hydrated throughout the day.

“Michael and I are excited to welcome Bruce to the BioSteel team,” said Celenza, Co-Founder of BioSteel. “We are deeply committed to the long-term success of BioSteel, and with Bruce’s track record of championing brands, we are confident that he will progress the achievement of our business objectives, including cementing BioSteel at the forefront of the sports hydration category. We look forward to working with him to bring to fruition the incredible opportunities that lie ahead for BioSteel.”

Anderson College & Westervelt College Students Eligible for Shoppers Drug Mart Funding

0

 

Anderson College & Westervelt College Students Eligible for Shoppers Drug Mart Funding – Financial Support to Spur Pharmacy Technician Professional Registration
Anderson College of Health, Business and Technology is thrilled to announce that students enrolled in both Anderson’s and Westervelt’s Pharmacy Technician program will have the opportunity to enroll in the Technician Licensing Assistance Program (TLAP) developed by Shoppers Drug Mart’s Central Pharmacy Services (CPS).
TLAP is designed to assist and financially support pharmacy assistants working at Central Pharmacy Services to become fully registered as Pharmacy Technicians. Anderson College and CPS will conduct Open Houses to provide details to interested students.
“Pharmacy Technicians have been vital to our ability to support our partner pharmacies in the delivery of exceptional patient care. We are grateful for the opportunity to reduce financial barriers and support individuals wishing to join this great profession” said Matt Koehler, Senior Operations Director of Central Pharmacy Services.

“Our deepest appreciation goes to Shoppers Drug Mart for creating this innovative solution to support tomorrow’s Pharmacy Technicians. This is an incredible opportunity for students in our CCAPP accredited Pharmacy Technician program, not only because they may receive financial support for their education, but they will also be able to be part of Shoppers Drug Mart Organization and CPS environment alongside individuals and teams of highly regarded healthcare professionals,” said Heather Yang, Chief Executive Officer of Anderson College.

“Our commitment to our students is to provide superior educational and training experiences, ensuring they graduate with the skills and knowledge to succeed within their respective fields,” said Rose Elia, Chief Operating Officer of Anderson College. “This partnership empowers our Pharmacy Technician students to learn hands-on, serving patients, and provides a clear pathway for them to become licensed professionals, removing any barriers by providing financial support.”

TLAP funding covers a 100% reimbursement for registration and licensing fees and an 80% reimbursement of Pharmacy Technician program costs up to a maximum of $12,000.* Eligible Anderson College and Westervelt College students must be entitled to study/work in Canada, registered as a Pharmacy Technician student and be employed full-time or part-time (practicum training) within a Central Pharmacy Services.*

Virtual Open Houses to provide further details about the TLAP program and how to apply, will be held in the coming days.

*Terms and Conditions Apply. For more information on the TLAP Funding opportunity for students of our Pharmacy Technician program, please email info@andersoncollege.com.

Pharmacist-Led Health Clinic to Open in Lethbridge, Alberta

0

 

Alberta’s first pharmacist-led primary healthcare clinic will open its doors to new patients in Lethbridge. Located inside the Lethbridge Real Canadian Superstore at 3515 Mayor Magrath Dr S, the Pharmacist Walk-in Clinic will offer a range of healthcare services to patients, including assessment and treatment of common ailments and injuries.
Access to primary healthcare services has been an ongoing issue across the country for some time and was most recently exacerbated by Covid-19. The expanded scope of practice for pharmacists in Alberta, however, is making it easier for patients to get access to the services they need.
Pharmacists in the province have the ability to assess patients and prescribe medications for minor illnesses and injuries, administer vaccines and other medications by injection, support chronic disease management and order and receive lab results. Making these services available in a pharmacist clinic setting will mean a reduction in urgent care and emergency room visits and ultimately can lead to better health outcomes for patients.

“Pharmacists in Alberta are uniquely positioned to relieve some of the burden on the province’s healthcare system and this innovative clinic will make access to care easier for residents in Lethbridge,” said Jeff Leger, head of pharmacy at Loblaw Companies Limited, and President, Shoppers Drug Mart. “We applaud the Government of Alberta for their support of pharmacy and for the work they continue to do, making healthcare more accessible to Albertans through pharmacy.”

The opening of the Pharmacist Walk-in Clinic is another way Loblaw is living up to its purpose to help Canadians live life well. The clinic adds to the company’s network of healthcare professionals and its national infrastructure that supports a variety of healthcare services through which Loblaw delivers care and wellness services to millions of Canadians weekly – both in-store and virtually, making healthcare more accessible, and convenient and seamless.

To support research and teaching at the clinic, Loblaw has provided a $500,000 grant to the University of Alberta. The grant will enable research and evaluation of innovative models of care implemented at the Pharmacist Walk-in Clinic and provide training opportunities for pharmacy students to complete clinical placements in a unique, community-based clinic environment. There will also be opportunities for collaborative care with other healthcare providers to foster a complete approach to patient care.

“This endeavour by Loblaw and the University of Alberta’s Faculty of Pharmacy and Pharmaceutical Sciences is an exciting one for our students, faculty and the Lethbridge community,” said Interim Dean, Christine Hughes. “The Pharmacist Walk-in Clinic will provide our students with fantastic opportunities for experiential learning and collaboration as well as serve as a key primary care location making healthcare more accessible to the people of Lethbridge.”

Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2022

0

 

Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial results for the fourth quarter and fiscal year 2022, which ended March 31, 2022.
 

Commenting on the fiscal year results (changes shown vs. fiscal 2021), Cyanotech’s Chief Executive Officer Emeritus and Chief Scientific Officer, Gerald R. Cysewski, Ph.D., said:

“Net sales increased to $36.0 million in the fiscal year, 11.2% over the prior year, with an improved gross profit as a result of lower cost of spirulina due to higher production volumes and astaxanthin as a result of production efficiencies. We generated $2.4 million in cash from operations, deleveraged the Balance Sheet by $1.7 million and invested over $1.0 million in capital expenditures.”

“Two new solar power systems were installed in our facility continuing Cyanotech’s commitment to renewable energy. In addition to the 791 metric tons of carbon dioxide (CO2) emissions we currently offset annually with our existing solar power system, the two new systems further reduce CO2 emissions by 163 metric tons per year.”

“After 39 years with Cyanotech, I have stepped down from my position at Cyanotech as Chief Executive Officer and as a member of the Board of Directors (‘Board’) effective June 16, 2022, to have more personal time in my latter years. My time at Cyanotech has been both challenging and very rewarding. I will assume the position of CEO Emeritus and remain as Chief Scientific Officer. I will be available for consultation on business strategy on an as needed basis. I want to sincerely thank shareholders and employees for their support throughout the years.”

“Matt Custer has been appointed as President and Chief Executive Officer and as a member of the Board effective June 16, 2022. Matt has been the President of the Company since May 2021. He is a very talented and insightful leader, and I am confident the company is in good hands.”

“I am honoured and humbled to lead the organization and thank Gerry for creating a legacy for all of us to continue to uphold,” commented Matt Custer, President and Chief Executive Officer.

Fiscal Year 2022

Cyanotech reported net sales of $35,968,000 for fiscal 2022 compared to $32,345,000 in fiscal 2021, an increase of 11.2%. Gross profit was $13,566,000, with gross profit margin of 37.7%, compared to gross profit of $11,117,000 and gross profit margin of 34.4%. Operating income was $2,574,000 compared to operating income of $84,000.

Net income was $2,154,000 or $0.35 per diluted share, compared to net income of $920,000 or $0.15 per diluted share. Net income in fiscal 2021 includes $1,389,000, including accrued interest of $8,000 for the forgiveness of the loan under the Paycheck Protection Program.

Fourth Quarter Fiscal 2022

Cyanotech reported net sales of $8,126,000 for the fourth quarter of fiscal year 2022 compared to $9,438,000 in the fourth quarter of fiscal 2021, a decrease of 13.9%. Gross profit was $2,894,000 with gross profit margin of 35.6%, compared to gross profit of $2,771,000 and gross profit margin of 29.4% in the fourth quarter of fiscal 2021. Operating income was $364,000 compared to operating loss of $24,000 in the fourth quarter of fiscal 2021. Net income was $277,000, or $0.04 per diluted share, compared to net loss of $200,000, or ($0.03) per diluted share in the fourth quarter of fiscal 2021.

Oragin Foods Inc. Reports First Quarter Results

0

 

The Canadian multi-faceted food company operating a Consumer Packaged Goods (CPG) Division where new and innovative food and beverage brands are developed, acquired, grown and commercialized as well as a Retail Division that operates one of Canada’s leading natural and organic food retailers, Organic Garage.

The Company is pleased to announce its financial results for the quarter ended April 30, 2022 (“Q1”). The Company has a Fiscal Year End of January 31. All figures presented are in Canadian Dollars, the Company’s functional currency.

Q1 Financial Results (comparison to the quarter ended April 30, 2021);

Net loss of $650,278 compared to $907,013 for the quarter ended April 30, 2021;
Store wages and benefits decreased by 11.7% due to management of staffing and improved efficiencies.

Sales decreased from $7.0 million to $5.7 million and was significantly impacted by Organic Garage’s renovation to one of its older retail store locations as well as changes to Government COVID-19 lockdown policies compared to the previous comparative period;
Gross Profit of $1,604,718 compared to $2,029,495 for the quarter ended April 30, 2021;
Net loss: The Company had a net loss of $650,278 for the quarter ended April 30, 2022, compared to a net loss of $907,013 for the quarter ended April 30, 2021. Net loss was attributed to a decrease in sales due to the Company’s decision to complete significant renovations at one of the older Organic Garage retail locations, non-cash stock-based compensation of $91,044, and costs incurred during the renovation, offset by decreases in store wages and benefits, professional fees and costs savings related to the Company’s phase-out of warehouse operations.In February 2022, the Company announced the change of its name from Organic Garage Ltd. to Oragin Foods Inc. and the launch of a Consumer Packaged Goods (CPG) Division which currently has one portfolio company, the Future of Cheese, and separate operations through ORAGIN’s Retail Division (Organic Garage).

Matt Lurie, CEO of ORAGIN, commented, “We achieved several operational goals during the quarter, including a significant renovation to one of our locations. The impact of the renovations was felt through our reported results; however, we expect that the short-term negative impacts will be offset by the long-term expectations for the location, including enhanced customer experience and operational efficiencies. Consistent branding and unified offerings across all our locations is a focus for the Company with our existing locations as we plan for future store expansion. The Company now has the majority of its locations with consistent award-winning branding and services, and the decision to engage in the renovation during this time was part of our long-term planning.

“In relation to the Future of Cheese, during Q1 we were excited to announce the addition of industry executive Matt Merson and continue to focus on both domestic expansion and entrance into the U.S. market. The CPG Division continues to actively engage and evaluate select M&A opportunities to grow our portfolio and our bottom line.”

“Looking forward through the rest of the fiscal year, we are expecting fiscal improvements for the associated areas of our operations that faced non-recurring expenses last year. Management continues to focus on incremental operating expense reduction while at the same time maintaining and improving our product and service offering at each of our locations. We acknowledge the challenges facing the business in regard to in-store sales and are working diligently to ensure that we are navigating the macro economic environment that is weighing heavily on businesses across the retail spectrum with strategy and purpose. We are excited for the go forward path of ORAGIN and both of our divisions continue to show opportunity for growth.”

Kensing Announces Acquisition of Vitae Naturals

0

 

Kensing, LLC a leading manufacturer of Natural Vitamin E, Plant Sterols and high-purity surfactants, and a portfolio company of One Rock Capital Partners, LLC (“One Rock”), announced its acquisition of Vitae Naturals (“Vitae”), a leading producer of Plant Sterol Esters and Non-GMO Natural Vitamin E derivatives for the food, nutrition and skincare end-markets.
“We are pleased to bring Vitae Naturals into the Kensing family,” said Serge Rogasik, Chief Executive Officer of Kensing. “This acquisition is highly complementary, strengthens our footprint in Europe and enables further expansion in food ingredients. This is an exciting time for both companies and we look forward to partnering with the Vitae team to accelerate our growth objectives.”

Founded in 2000 in Talavera de la Reina, Spain, Vitae Naturals manufactures Plant Sterol Esters under the Vitasterol® brand and Natural Vitamin E derivatives under the Vitapherole® brand. Plant Sterol Esters have been clinically proven to naturally lower cholesterol and help fight heart disease when added to margarine spreads, yogurts, and supplements. Natural Vitamin E derivatives are primarily used in vitamin supplements and as natural antioxidants in food and cosmetic applications. Vitae Naturals serves a large set of global customers in more than 40 countries across five continents.

“Our businesses share similar values and we are delighted to become a part of the Kensing team,” said Rafael Cano Mariblanca, General Manager of Vitae Naturals. “Kensing provides a strong platform to build upon our position in our existing markets and expand further into the personal care market. Together, we have a truly diversified footprint with numerous opportunities for growth.”

Inflation causing price pains for Edmonton’s small grocers and their customers

0

 

Food costs are up 9.7 per cent over last year, latest Statistics Canada figures show / By: Kashmala Fida Mohatarem
Inflation pressures have forced Nunu Deselgne to raise prices on every item in her Edmonton grocery store, Habesha African Market, with two exceptions: eggs and milk.

“Those are a necessity for people,” Deselgne told CBC’s Edmonton AM on Thursday.  “So we’re taking a hit on those.”

Her store, at 10418 107th Ave., is in one of the city’s lower-income neighbourhoods in central Edmonton.

With prices increasing with almost every new shipment that arrives, Deselgne isn’t sure how long she can keep swallowing her costs.

Deselgne is not alone. Grocers in Edmonton are having to raise prices on the foods they sell as inflation, combined with labour shortage and supply-chain issues, have driven costs through the roof.

On Wednesday, Statistics Canada reported that Canada’s inflation rate rose to 7.7 per cent in May, the highest in 40 years. Grocery prices have increased 9.7 per cent over the past year.

“It’s just constantly going higher and higher by week,” Deselgne said. “It’s quite stressful.”

The Spice Centre, at 9280 34th Ave. in Mill Woods, has also had to increase prices, partly due to increasing shipping costs.

“We have been in business for over 30 years now and we have not seen price changes like these, ever,” Spice Centre co-owner and manager Aman Bindra said.

Prices are up, but profits are down, he said.

The store caters to a significant South Asian and Caribbean population and orders a lot of its products from India and the Caribbean.

Before the pandemic, a container that cost Bindra $5,000 and take five to six weeks to arrive is now costing him around $15,000 and not arriving for months.

Pharmavite LLC, Invests $200 Million and Creates 225 New Jobs

0

 

Pharmavite LLC has announced plans to expand into the Columbus Region, investing more than $200 million and creating 225 new jobs. With this investment, Pharmavite will build a new 200,000 – 250,000-square-foot facility in New Albany, joining the Columbus Region’s growing life science industry, which spans R&D, technology and manufacturing operations.

Pharmavite’s facility will be located at 13312 Jug Street Road NW in New Albany, pending local approvals and site acquisition. Expanding into the Columbus Region will help the company add production capacity and enhance its Midwest and East Coast market service. The company is investing in the construction of the new facility, machinery and equipment, with production expected to start by the end of 2024.

“Pharmavite is excited to announce a major expansion into the Columbus Region, which is rapidly emerging as a leading national hub for science, innovation and technology companies,” said Jeff Boutelle, CEO of Pharmavite. “As a proud Ohioan, I look forward to leading Pharmavite into this new era in which we will develop new reach and capabilities while striving to become an important part of the Columbus and New Albany communities.”

Pharmavite manufactures its products in the United States. This marks the company’s fourth manufacturing facility and the second investment outside the California-based company’s home state. Founded in 1971, Pharmavite’s last expansion took place in 2013 with a facility in Alabama which has grown to full capacity. The new facility will primarily produce products for its Nature Made & MegaFood brands. Nature Made is the leading national vitamin and supplement broadline brand, with 50 years of delivering high-quality products that are backed by science and ranked as the #1 Pharmacist Recommended vitamin and supplement brand.

“As we continue to expand and strengthen our health and life science cluster, we’re excited to welcome a leading company like Pharmavite to join the ecosystem,” said Michael Loges, economic development manager at the City of New Albany. “Pharmavite’s focus on wellness and nutrition align with New Albany’s strengths and values, so we’re excited to integrate them as partners in our business community and look forward to presenting this project to New Albany City Council.”

From medical breakthroughs to cutting-edge technology, the Columbus Region is home to one of the most dynamic healthcare and life science industries in the country. In the last five years, the Columbus Region has granted over 8,700 degrees in biology, biomedical science, chemistry and pharmacy, and The Ohio State University ranks in the top 10 nationally in Biological and Biomedical Science Ph.D. completions – all contributing to a highly educated and prepared talent pool. New Albany is located in Franklin County, which is home to an estimated 1,316,756 residents.

“Pharmavite is a California-based life science company that will now grow its national brands with talent from Ohio, making this the 43rd project from the nation’s Coasts to choose to invest here since 2019!” said J.P. Nauseef, president and CEO of JobsOhio. “This investment brings a state-of-the-art facility and 225 new jobs that will support growing demand for Pharmavite’s vitamin supplements throughout the Midwest and East Coast.”

U.S Investors in Natural Health Trends (NASDAQ:NHTC) have unfortunately lost 67% over the last five years

0

 

According to Yahoo finance, intelligent long term investing is the way to go. But along the way some stocks are going to perform badly. Zooming in on an example, the Natural Health Trends Corp. (NASDAQ:NHTC) share price dropped 81% in the last half decade. We certainly feel for shareholders who bought near the top. Furthermore, it’s down 27% in about a quarter. That’s not much fun for holders. However, one could argue that the price has been influenced by the general market, which is down…
 Read more:
However, one could argue that the price has been influenced by the general market, which is down 15% in the same timeframe. While a drop like that is definitely a body blow, money isn’t as important as health and happiness.
It’s worthwhile assessing if the company’s economics have been moving in lockstep with these underwhelming shareholder returns, or if there is some disparity between the two. So let’s do just that.
There is no denying that markets are sometimes efficient, but prices do not always reflect underlying business performance. One way to examine how market sentiment has changed over time is to look at the interaction between a company’s share price and its earnings per share (EPS).
During the five years over which the share price declined, Natural Health Trends’ earnings per share (EPS) dropped by 57% each year. The share price decline of 28% per year isn’t as bad as the EPS decline. So investors might expect EPS to bounce back — or they may have previously foreseen the EPS decline. With a P/E ratio of 73.30, it’s fair to say the market sees a brighter future for the business.

You can see how EPS has changed over time in the image below (click on the chart to see the exact values).

What About Dividends?

When looking at investment returns, it is important to consider the difference between total shareholder return (TSR) and share price return. The TSR incorporates the value of any spin-offs or discounted capital raisings, along with any dividends, based on the assumption that the dividends are reinvested. It’s fair to say that the TSR gives a more complete picture for stocks that pay a dividend. In the case of Natural Health Trends, it has a TSR of -67% for the last 5 years. That exceeds its share price return that we previously mentioned. And there’s no prize for guessing that the dividend payments largely explain the divergence!

A Different Perspective

Although it hurts that Natural Health Trends returned a loss of 12% in the last twelve months, the broader market was actually worse, returning a loss of 17%. Of far more concern is the 11% p.a. loss served to shareholders over the last five years. While the losses are slowing we doubt many shareholders are happy with the stock. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. Consider for instance, the ever-present spectre of investment risk.
Published and source: Yahoo finance

Canadian Pharmacists Association

0

 

 

PO APPEARS BEFORE HEALTH COMMITTEE

Dr. Danielle Paes, CPhA’s chief pharmacist officer, appeared before the House of Commons Standing Committee on Health on June 1 as a witness for its study on the emergency situation facing Canadians in light of the COVID-19 pandemic. CPhA’s remarks focused on the pandemic’s impact on drug shortages and patient access to care across Canada, and the expanded services that have enabled pharmacists to enhance care for their patients.